BM from advanced gastric cancer was correlated with VEGF expression, and metformin therapy might be helpful for modulating the metastasis capacity via reducing the expression of VEGF and blocking epithelial-to-mesenchymal transition (EMT) (83). This evidence concerns the gene VEGFA and gastric cancer.